Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment (Q37702449)
Jump to navigation
Jump to search
scientific article published on 08 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment |
scientific article published on 08 March 2017 |
Statements
1 reference
Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment (English)
1 reference
Bo Wu
1 reference
Shu-Ting Lu
1 reference
Liu-Jie Zhang
1 reference
Ren-Xi Zhuo
1 reference
Hai-Bo Xu
1 reference
Shi-Wen Huang
1 reference
8 March 2017
1 reference
1 reference
1853-1862
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference